Search
for
Sort by
Research 631–660 of 1000+
- Alopecia Areata
- MOST IMPORTANT SKIN DISEASES OF CHILDRENTheir Diagnosis and Treatment
- The follicular microbiome in hair-follicle-associated inflammatory diseases: A systematic review
- SILENT PATCHES, LOUD SCIENCE: REVISITING ALOPECIA AREATA
- SILENT PATCHES, LOUD SCIENCE: REVISITING ALOPECIA AREATA
- A RARE CASE OF SIMULATANEOUS DEVELOPMENT OF ALOPECIA AREATA UNIVERSALIS AND TYPE 1 DIABETES MELLITUS
- Assessment of Quality of Life among Patients with Alopecia Areata
- The impact of appendectomy on the occurrence of alopecia areata: a retrospective cohort study
- Alopecia areata in childhood, clinical manifestations and therapeutic approaches
- CAPILLARY DISEASES IN PATIENTS WHO HAD COVID-19
- Clinicoepidemiological profile, precipitating factors and severity indicators in alopecia areata in Manipur
- Психоэмоциональные Особенности Женщин С Алопецией = Psychoemotional Characteristicsin Women With Alopecia
- Diseases of the Hair and Scalp
- Diseases of the hair and scalp
- COMPARATIVE STUDY OF TROPONIN I LEVEL IN ALOPECIA AREATA, ANDROGENIC ALOPECIA AND HEALTHY CONTROL SUBJECTS
- P132 Quality of life, psychopathologic symptoms and personality disorders in subjects with androgenetic alopecia
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Alopecia areata – Current understanding and management
- Factors Affecting the Psychosocial Distress of Patients with Alopecia Areata: A Nationwide Study in Korea
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- Risk profile of non-cicatricial alopecia in females
- Canine alopecia X-Like disorder
- Canine alopecia X-Like disorder
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Resident Memory T Cells in Autoimmune Skin Diseases
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Systemic Autoimmune Diseases
- Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata